NCT04840199 · Interventional trial
A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.
Overall registry status Terminated
Phase 2
Conditions CMV, Cytomegalovirus, HIV Infections
Delaware Valley sites
- Penn Therapeutics, CRS · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory